BioReperia
Accelerate drug discovery and cancer treatment
- CEO: Annika Ericson
- First investment year: 2019
- Fund: Eastern Mid Sweden
- Business sector: Life Science
BioReperia
BioReperia increases the success rate in clinical trials using zebrafish models. Their innovative models can determine which medicine that is most efficient in treating a patient´s specific tumor within a week.